Briggs Morrison, Director at Syndax Pharmaceuticals Inc (SNDX), sold 105,710 shares at $21.41 ($2.3M) on 2023-05-09, disclosed to the SEC on 2023-05-10.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.41 | 52,855 | $1.1M | 50.0% |
| 2 | $21.41 | 52,855 | $1.1M | 50.0% |
| Total | $21.41 avg | 105,710 | $2.3M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |